CLINICAL_TRIALS
trial_result
· 2011-06-23
Clinical Trial Update: A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer [Phase 3]
Summary
Phase 3 study of Xeloda (capecitabine) in women with high-risk breast cancer has completed, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2011-06-23